Despite Earnings Miss, Our Liquid Biopsy Play Gets the Good Housekeeping "Seal of Approval"By William Patalon III, Executive Editor, Money Morning • August 5, 2016Start the conversationLeave a Reply Click here to cancel reply.Your email address will not be published. Required fields are marked *Name * Email * Website 8 × nine = Comment Some HTML is OK Sign me up for the Money Morning newsletter William Patalon IIIThere's an old adage in business that I know you're familiar with: "You have to spend money to make money."And after looking at the second-quarter earnings report of our "Liquid Biopsy" play, Trovagene Inc. (Nasdaq: TROV), that's exactly the force at work here.The small-cap biotech firm reported a loss that was bigger than expected, and that sent shares down nearly 8% today.This is premium content for Private Briefing subscribers only. As the executive editor of Money Morning, Bill Patalon has perfected a secret investment strategy that could help you put an extra $125K into your portfolio - this year. To date, Bill has used this strategy to pick 257 winning investments, including 192 double- and triple-digit peak gains. Once you see the secret, you'll immediately understand why it works so well.